CC chemokine receptor-7 on dendritic cells is induced after interaction with apoptotic tumor cells: Critical role in migration from the tumor site to draining lymph nodes

Cancer Research

Volumn 60, Issue 8, 2000, Pages 2209-2217

  Hirao, Motohiro ^a   Onai, Nobuyuki ^b   Hiroishi, Kazumasa ^a   Watkins, Simon C ^a   Matsushima, Kouji ^b   Robbins, Paul D ^a   Lotze, Michael T ^a   Tahara, Hideaki ^a,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR;

ANIMAL CELL; ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; DENDRITIC CELL; FEMALE; IMMUNOREGULATION; LYMPH NODE METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; CELL MOVEMENT; CHEMOKINES, CC; COCULTURE TECHNIQUES; DENDRITIC CELLS; FEMALE; FIBROSARCOMA; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; LYMPH NODES; MACROPHAGE INFLAMMATORY PROTEIN-1; MICE; MICE, INBRED C57BL; RECEPTORS, CHEMOKINE; RNA, MESSENGER; TH1 CELLS; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED; ULTRAVIOLET RAYS;

EID: 0034655262     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Steinman, R. M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol., 9: 271-296, 1991.
2. Macatonia, S. E., Taylor, P. M., Knight, S. C., and Askonas, B. A. Primary stimulation by dendritic cells induces antiviral proliferative and cytotoxic T cell responses in vitro. J. Exp. Med., 169: 1255-1264, 1989.
3. Banchereau, J., and Steinman, R. M. Dendritic cells and the control of immunity. Nature (Lond.), 392: 245-252, 1998.
4. Tsujitani, S., Furukawa, T., Tamada, R., Okamura, T., Yasumoto, K., and Sugimachi, K. Langerhans cells and prognosis in patients with gastric carcinoma. Cancer (Phila.), 59: 501-505, 1987.
5. Gallo, O., Bianchi, S., Giannini, A., Gallina, E., Libonati, G. A., and Fini-Storchi, O. Correlations between histopathological and biological findings in nasopharyngeal carcinoma and its prognostic significance. Laryngoscope, 101: 487-493, 1991.
6. Zeid, N. A., and Muller, H. K. S100 positive dendritic cells in human lung tumors associated with cell differentiation and enhanced survival. Pathology, 25: 338-343, 1993.
7. Cumberbatch, M., and Kimbler, I. Tumor necrosis factor-α is reacquired for accumulation of dendritic cells in draining lymph nodes and optimal contact sensitization. Immunology, 84: 31-35, 1995.
8. Mayordomo, J. I., Zorina, T., Storkus, W. J., Zitvogel, L., Celluzzi, C., Falo, L. D., Melief, C. J., Ildstad, S. T., Martin Kast, W., Deleo, A. B., and Lotze, M. T. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumor immunity. Nat. Med., 1: 1297-1302, 1995.
9. Zitvogel, L., Mayordomo, J. I., Tjandrawan, T., Deleo, A. B., Clarke, M. R., Lotze, M. T., and Storkus, W. J. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J. Exp. Med., 183: 87-97, 1996.
10. Nishioka, Y., Hirao, M, Robbins, P. D., Lotze, M. T., and Tahara, H. Induction of systemic and therapeutic antitumor immunity using intratumoral injection of dendritic cells genetically modified to express interleukin 12. Cancer Res., 59: 4035-4041, 1999.
11. Dieu, M. C., Vanbervliet, B., Vicari, A., Bridon, J. M., Oldham, E., Ait-Yahia, S., Briere, F., Zlotnik, A., Lebecque, S., and Caux, C. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med., 188: 373-386, 1998.
12. Sozzani, S., Allavena, P., D'Amico, G., Luini, W., Bianchi, G., Kataura, M., Imai, T., Yoshie, O., Bonecchi, R., and Mantovani, A. Differential regulation of chemokine receptors during dendrilic cell maturation: a model for their trafficking properties. J. Immunol., 161: 1083-1086, 1998.
13. Yanagihara, S., Komura, E., Nagafune, J., Watarai, H., and Yamaguchi, Y. ERI1/ CCR7 is a new member of dendritic cell chemokine receptor that is up-regulated upon maturation. J. Immunol., 161: 3096-3102, 1998.
14. Kellermann, S-A., Hudek, S., Oldham, E. R., Liu, Y-J., and McEvoy, L. M. The CC chemokine receptor-7 ligands 6Ckine and macrophage inflammatory protein-3β are potent chemoattractants for in vitro-and in vivo-derived dendritic cells. J. Immunol., 162: 3859-3864, 1999.
15. Gunn, M. D., Kyuwa, S., Tain, C., Kakiuchi, T., Matsuzawa, A., Williams, L. T., and Nakano, H. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J. Exp. Med., 189: 451-460, 1999.
16. Sallusto, F., Palermo, B., Lenig, D., Miettinen, M., Matikainen, S., Julkunen, I., Forster, R., Burgstahler, R., Lipp. M., and Lanzavecchia, A. Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur. J. Immunol., 29: 1617-1625, 1999.
17. Chan, V. W. F., Kothakota, S., Rohan, M. C., P.-Lustan, L., Gardner, J. P., Wachowicz, M. S., Winter, J. A., and Williams, L. T. Secondary lymphoid-tissue chemokine (SLC) is chemotactic for mature dendritic cells. Blood, 93: 3610-3616, 1999.
18. Nagira, M., Imai, T., Hieshima, K., Kusuda, J., Ridanpaa, M. Takagi, S., Nishimura, M., Kakizaki, M., Nomiyama, H., and Yoshie, O. Molecular cloning of a novel human CC chemokine secondary lymphoid-tissue chemokine that is a potent chemoattractant for lymphocytes and mapped to chromosome 9p13. J. Biol. Chem., 272: 19518-19524, 1997.
19. Yoshie, O., Imai, T., and Nomiyama, H. Novel lymphocyte-specific CC chemokines and their receptors. J. Leukoc. Biol., 62: 634-644, 1997.
20. Yoshida, R., Nagira, M., Kitaura, M., Imagawa, N., Imai, T., and Yoshie, O. Secondary lymphoid-tissue chemokine is a functional ligand for the CC chemokine receptor CCR7. J. Biol. Chem., 273: 7118-7122, 1998.
21. Campbell, J. J., Bowman, E. P., Murphy, K., Youngman, K. R., Siani, M. A., Thompson, D. A., Wu, L., Zlotnik, A., and Butcher, E. C. 6-C-kine (SLC), a lymphocyte adhesion-triggering chemokine expressed by high endotherium, is an agonist for the MIP-3β receptor CCR7. J. Cell Biol., 141: 1053-1059, 1998.
22. Saeki, H., Moore, A. M., Brown, M. J., and Hwang, S. T. Secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J. Immunol., 162: 2472-2475, 1999.
23. Halliday, G. M., Reeve, V. E., and Barnetson, R. St. C. Langerhans cell migration into ultraviolet light induced squamous skin tumors is unrelated to anti-tumor immunity. J. Investig. Dermatol., 97: 830-834, 1991.
24. Dranoff, G., Jaffee, E., Lazenby, A., Golumbek, P., Levitsky, H., Brose, K., Jackson, V., Hamada, H., Pardoll, D., and Mulligan, R. C. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulales potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA, 90: 3539-3543, 1993.
25. Cormack, B. P., Valdivia, R. H., and Falkow, S. FACS-optimized mutants of the green fluorescent protein (GFP). Gene, 173: 33-38, 1996.
26. Tahara, H., Zitvogel, L., Storkus, W. J., Zeh, H. J., III, McKinney, T. G., Schreiber, R. D., Gubler, U., Robbins, P. D., and Lotze, M. T. Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector. J. Immunol., 154: 6466-6474, 1995.
27. Kotani, H., Newton, P. B., III, Zhang, S., Chiang, Y. L., Otto, E., Weaver, L., Blaese, R. M., Anderson, W. F., and McGarrity, G. J. Improved methods of retroviral vector transduction and production for gene therapy. Hum. Gene Ther., 5: 19-28, 1994.
28. Bahnson, A. B., Dunigan, J. T., Baysal, B. E., Mohney, T., Atchison, R. W., Nimgaonkar, M. T., Ball, E. D., and Barranger, J. A. Centrifugal enhancement of retroviral mediated gene transfer. J. Virol. Methods, 54: 131-143, 1995.
29. Horan, P. K., Melnicoff, M. J., Jensen, B. D., and Slezak, S. E. Fluorescent cell labeling for in vivo and in vitro cell tracking. Methods Cell Biol., 33: 469-490, 1990.
30. Slezak, S. E., and Horan, P. K. Fluorescent in vivo tracking of hematopoietic cells. Part 1: technical considerations. Blood, 74: 2171-2177, 1989.
31. Albert, M. L., Sauter, B., and Bhardwaj, N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature (Lond.), 392: 86-89, 1998.
32. Oin, S., LaRosa, G., Campbell, J. J., Smith-Heath, H., Kassam, N., Shi, X., Zeng, L., Butcher, E. C., and Mackay, C. R. Expression of monocyte chemoattractant protein-1 and interleukin-8 receptors on subsets of T cells: correlation with trans-endothelial chemotactic potential. Eur. J. Immunol., 26: 640-647, 1996.
33. Barrat-Boyes, S. M., Watkins, S. C., and Finn, O. J. In vivo migration of dendritic cells differentiated in vitro: a chimpanzee model. J. Immunol., 158: 4543-4547, 1997.
34. Ingulli, E., Mondino, A., Khoruts, A., and Jenkins, M. K. In vivo detection of dendritic cell antigen presentation to CD4+ T cells. J Exp. Med., 185: 2133-2141, 1997.
35. Rubio, C. A., Kumagai, J., Kanamori, T., and Nakamura, K. Apoptosis in flat neoplasias of the colorectal mucosa. In Vivo (Athens), 9: 173-176, 1995.
36. Valenti, M-T., Azzarello, G., Vinante, O., Manconi, R., Balducci, E., Guidolin, D., Chiavegato, A., and Sartore, S. Differentiation, proliferation and apoptosis levels in human leimyoma and leimyosarcoma. J. Cancer Res. Clin. Oncol., 124: 93-105, 1998.
37. 2+-dependent mechanism. J. Exp. Med., 186: 467-472, 1997.
38. Papec, R. J. Spontaneous regression of cancer: possible mechanisms. In Vivo (Athens), 12: 571-578, 1998.
39. 5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J. Exp. Med., 188: 1359-1368, 1998.
40. Willimann, K., Legler, D. F., Loetscher, M., Roos, R. S., Delgado, M. B., Clark-Lewis, I., Baggiolini, M., and Moser, B. The chemokine SLC is expressed in T cell areas of lymph nodes and mucosal lymphoid tissues and attracts activated T cells via CCR7. Eur. J. Immunol., 28: 2025-2034, 1998.
41. Ngo, V. N., Tang, H. L., and Cyster, J. G. Epstein-Barr virus-induced molecule 1 ligand chemokine is expressed by dendritic cells in lymphoid tissues and strongly attracts naive T cells and activated B cells. J. Exp. Med., 188: 181-191, 1998.